 | • レポートコード：MRC2203A005 • 出版社/出版日：Persistence Market Research / 2021年1月 • レポート形態：英文、PDF、280ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社の本調査レポートでは、世界の液体塞栓市場について調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、市場背景、市場状況、新型コロナウイルス感染症の影響分析、市場規模分析・予測、価格分析、製品別（液体塞栓バイアル、液体塞栓プレフィルド注射剤）分析、疾患別（脳動静脈奇形（bAVM）、腫瘍塞栓術、放射線科、心臓病）分析、エンドユーザー別（病院、外来手術センター、独立専門センター）分析、地域別分析、市場構造分析、競争分析、仮定、調査手法など、以下の内容でまとめております。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・市場背景 ・市場状況 ・新型コロナウイルス感染症の影響分析 ・市場規模分析・予測 ・価格分析 ・世界の液体塞栓市場規模：製品別（液体塞栓バイアル、液体塞栓プレフィルド注射剤） ・世界の液体塞栓市場規模：疾患別（脳動静脈奇形（bAVM）、腫瘍塞栓術、放射線科、心臓病） ・世界の液体塞栓市場規模：エンドユーザー別（病院、外来手術センター、独立専門センター） ・世界の液体塞栓市場規模：地域別 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Liquid Embolic Market – Scope of Report
The latest publication by Persistence Market Research on the global liquid embolic market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the liquid embolic market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.
Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research’s study. This research study can support readers to know the demand for liquid embolic products and the quantitative development opportunities during the study period.
The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the liquid embolic market. The insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the liquid embolic market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.
Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the liquid embolic market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.
Key Market Segments
Persistence Market Research’s study on the liquid embolic market offers information divided into four important segments – product, indication, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Product
Liquid Embolic Vials
Liquid Embolic Prefilled Injectables
Indication
Brain Arterio-Venous Malformations (bAVM)
Tumor Embolization
Radiology
Cardiology
End User
Hospitals
Ambulatory Surgical Centers
Independent Speciality Centers
Region
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa
Key Questions Answered in Report
Which regions will continue to remain the most profitable markets for liquid embolic products over the coming years?
How will changing trends impact the market?
How has the COVID-19 crisis impacted market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will impact the market?
How can companies in the liquid embolic market avail themselves the growth opportunities in developed and emerging sectors?
Research Methodology
In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the liquid embolic market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research’s projections on the growth prospects of the liquid embolic market more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion & Exclusion
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Market Background
4.1. Macro-Economic Factors
4.1.1. GDP Growth Outlook
4.1.2. Global Healthcare Industry Outlook
4.1.3. Increasing Per Capita Healthcare Liquid Embolizing
4.1.4. Income Per Capita Outlook
4.2. Forecast Factors – Relevance & Impact
4.2.1. GDP Growth
4.2.2. Healthcare Liquid Embolizing
4.2.3. Prevalence of Chronic Diseases
4.2.4. Product Adoption Rate
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity Analysis
5. Market Context
5.1. Technology Roadmap
5.2. Key Regulatory Scenario
5.3. Value Chain Analysis
5.4. Production Analysis
5.5. Disease Epidemiology
5.6. Key Products USP Analysis
6. COVID19 Crisis Analysis
6.1. COVID19 and Impact Analysis
6.1.1. Revenue by Product
6.1.2. Revenue by Indication
6.1.3. Revenue by End User
6.1.4. Revenue by Country
6.2. 2020 Market Scenario
7. Global Liquid Embolic Market Volume (Units) Analysis 2016-2020 and Forecast, 2021-2031
7.1. Historical Market Volume (Units) Analysis, 2016-2020
7.2. Current and Future Market Volume (Units) Projections, 2021-2031
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Liquid Embolic Market – Pricing Analysis
8.1. Regional Pricing Analysis by Product
8.2. Global Average Pricing Analysis Benchmark
9. Global Liquid Embolic Market Value Analysis 2016-2020 and Forecast, 2021-2031
9.1. Historical Market Value (US$ Mn) Analysis, 2016-2020
9.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Liquid Embolic Market Analysis 2016-2020 and Forecast 2021-2031, by Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis by Product, 2016-2020
10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Product, 2021-2031
10.3.1. Liquid Embolic Vials
10.3.2. Liquid Embolic Prefilled Injectable
10.4. Market Attractiveness Analysis by Product
11. Global Liquid Embolic Market Analysis 2016-2020 and Forecast 2021-2031, by Indication
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis by Indication, 2016-2020
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Indication, 2021-2031
11.3.1. brain Arterio-Venous Malformations (bAVM)
11.3.2. Tumor Embolization
11.3.3. Radiology
11.3.4. Cardiology
11.4. Market Attractiveness Analysis by Indication
12. Global Liquid Embolic Market Analysis 2016-2020 and Forecast 2021-2031, By End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis By End User, 2016-2020
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2021-2031
12.3.1. Hospitals
12.3.2. Ambulatory Surgical Centers
12.3.3. Independent Speciality Centers
12.4. Market Attractiveness Analysis by End User
13. Global Liquid Embolic Market Analysis 2016-2020 and Forecast 2021-2031, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2016-2020
13.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Region, 2021-2031
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. East Asia
13.3.5. South Asia
13.3.6. Oceania
13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region
14. North America Liquid Embolic Market Analysis 2016-2020 and Forecast 2021-2031
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
14.3.1. By Country
14.3.1.1. U.S.
14.3.1.2. Canada
14.3.2. By Product
14.3.3. By Indication
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants – Intensity Mapping
14.6. Drivers and Restraints – Impact Analysis
15. Latin America Liquid Embolic Market Analysis 2016-2020 and Forecast 2021-2031
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
15.3.1. By Country
15.3.1.1. Brazil
15.3.1.2. Mexico
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Product
15.3.3. By Indication
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.5. Key Market Participants – Intensity Mapping
15.6. Drivers and Restraints – Impact Analysis
16. Europe Liquid Embolic Market Analysis 2016-2020 and Forecast 2021-2031
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. Italy
16.3.1.3. France
16.3.1.4. U.K.
16.3.1.5. Spain
16.3.1.6. Russia
16.3.1.7. BENELUX
16.3.1.8. Rest of Europe
16.3.2. By Product
16.3.3. By Indication
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.5. Key Market Participants – Intensity Mapping
16.6. Drivers and Restraints – Impact Analysis
17. South Asia Liquid Embolic Market Analysis 2016-2020 and Forecast 2021-2031
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Thailand
17.3.1.3. Indonesia
17.3.1.4. Malaysia
17.3.1.5. Rest of South Asia
17.3.2. By Product
17.3.3. By Indication
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.5. Key Market Participants – Intensity Mapping
17.6. Drivers and Restraints – Impact Analysis
18. East Asia Liquid Embolic Market Analysis 2016-2020 and Forecast 2021-2031
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.1.4. Rest of East Asia
18.3.2. By Product
18.3.3. By Indication
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.5. Key Market Participants – Intensity Mapping
18.6. Drivers and Restraints – Impact Analysis
19. Oceania Liquid Embolic Market Analysis 2016-2020 and Forecast 2021-2031
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Product
19.3.3. By Indication
19.3.4. By End User
19.4. Market Attractiveness Analysis
19.5. Key Market Participants – Intensity Mapping
19.6. Drivers and Restraints – Impact Analysis
20. Middle East and Africa Liquid Embolic Market Analysis 2016-2020 and Forecast 2021-2031
20.1. Introduction
20.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
20.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. South Africa
20.3.1.3. Northern Africa
20.3.1.4. Turkey
20.3.1.5. Rest of Middle East and Africa
20.3.2. By Product
20.3.3. By Indication
20.3.4. By End User
20.4. Market Attractiveness Analysis
20.5. Key Market Participants – Intensity Mapping
20.6. Drivers and Restraints – Impact Analysis
21. Countries Liquid Embolic Market Analysis 2021 & 2031
21.1. Introduction
21.1.1. Market Value Proportion Analysis, By Key Countries
21.1.2. Global Vs. Country Growth Comparison
21.1.3. Pricing Analysis
21.2. U.S. Liquid Embolic Market Analysis
21.2.1. By Product
21.2.2. By Indication
21.2.3. By End User
21.3. Canada Liquid Embolic Market Analysis
21.3.1. By Product
21.3.2. By Indication
21.3.3. By End User
21.4. Mexico Liquid Embolic Market Analysis
21.4.1. By Product
21.4.2. By Indication
21.4.3. By End User
21.5. Brazil Liquid Embolic Market Analysis
21.5.1. By Product
21.5.2. By Indication
21.5.3. By End User
21.6. U.K. Liquid Embolic Market Analysis
21.6.1. By Product
21.6.2. By Indication
21.6.3. By End User
21.7. Germany Liquid Embolic Market Analysis
21.7.1. By Product
21.7.2. By Indication
21.7.3. By End User
21.8. France Liquid Embolic Market Analysis
21.8.1. By Product
21.8.2. By Indication
21.8.3. By End User
21.9. Italy Liquid Embolic Market Analysis
21.9.1. By Product
21.9.2. By Indication
21.9.3. By End User
21.10. Spain Liquid Embolic Market Analysis
21.10.1. By Product
21.10.2. By Indication
21.10.3. By End User
21.11. BENELUX Liquid Embolic Market Analysis
21.11.1. By Product
21.11.2. By Indication
21.11.3. By End User
21.12. Russia Liquid Embolic Market Analysis
21.12.1. By Product
21.12.2. By Indication
21.12.3. By End User
21.13. China Liquid Embolic Market Analysis
21.13.1. By Product
21.13.2. By Indication
21.13.3. By End User
21.14. Japan Liquid Embolic Market Analysis
21.14.1. By Product
21.14.2. By Indication
21.14.3. By End User
21.15. South Korea Liquid Embolic Market Analysis
21.15.1. By Product
21.15.2. By Indication
21.15.3. By End User
21.16. India Liquid Embolic Market Analysis
21.16.1. By Product
21.16.2. By Indication
21.16.3. By End User
21.17. Thailand Liquid Embolic Market Analysis
21.17.1. By Product
21.17.2. By Indication
21.17.3. By End User
21.18. Indonesia Liquid Embolic Market Analysis
21.18.1. By Product
21.18.2. By Indication
21.18.3. By End User
21.19. Malaysia Liquid Embolic Market Analysis
21.19.1. By Product
21.19.2. By Indication
21.19.3. By End User
21.20. Australia Liquid Embolic Market Analysis
21.20.1. By Product
21.20.2. By Indication
21.20.3. By End User
21.21. New Zealand Liquid Embolic Market Analysis
21.21.1. By Product
21.21.2. By Indication
21.21.3. By End User
21.22. GCC Countries Liquid Embolic Market Analysis
21.22.1. By Product
21.22.2. By Indication
21.22.3. By End User
21.23. Turkey Liquid Embolic Market Analysis
21.23.1. By Product
21.23.2. By Indication
21.23.3. By End User
21.24. South Africa Liquid Embolic Market Analysis
21.24.1. By Product
21.24.2. By Indication
21.24.3. By End User
21.25. Northern Africa Liquid Embolic Market Analysis
21.25.1. By Product
21.25.2. By Indication
21.25.3. By End User
22. Market Structure Analysis
22.1. Market Analysis by Tier of Companies
22.2. Market Concentration
22.3. Market Share Analysis of Top Players
22.4. Market Presence Analysis
22.4.1. By Regional Foot Print of Players
22.4.2. Product Foot Print by Players
22.4.3. Channel Foot Print by Players
23. Competition Analysis
23.1. Competition Dashboard
23.2. Competition Benchmarking
23.3. Competition Deep Dive
23.3.1. Medtronic
23.3.1.1. Overview
23.3.1.2. Product Portfolio
23.3.1.3. Analyst Commentary
23.3.1.4. Key Financials
23.3.1.5. Recent Developments
23.3.1.6. Sales Footprint
23.3.1.7. Strategy Overview
23.3.1.7.1. Marketing Strategy
23.3.1.7.2. Product Strategy
23.3.1.7.3. Channel Strategy
23.3.2. Meril Life Sciences Pvt Ltd.
23.3.2.1. Overview
23.3.2.2. Product Portfolio
23.3.2.3. Analyst Commentary
23.3.2.4. Key Financials
23.3.2.5. Recent Developments
23.3.2.6. Sales Footprint
23.3.2.7. Strategy Overview
23.3.2.7.1. Marketing Strategy
23.3.2.7.2. Product Strategy
23.3.2.7.3. Channel Strategy
23.3.3. Johnson & Johnson
23.3.3.1. Overview
23.3.3.2. Product Portfolio
23.3.3.3. Analyst Commentary
23.3.3.4. Key Financials
23.3.3.5. Recent Developments
23.3.3.6. Sales Footprint
23.3.3.7. Strategy Overview
23.3.3.7.1. Marketing Strategy
23.3.3.7.2. Product Strategy
23.3.3.7.3. Channel Strategy
23.3.4. Microvention Inc.
23.3.4.1. Overview
23.3.4.2. Product Portfolio
23.3.4.3. Analyst Commentary
23.3.4.4. Key Financials
23.3.4.5. Recent Developments
23.3.4.6. Sales Footprint
23.3.4.7. Strategy Overview
23.3.4.7.1. Marketing Strategy
23.3.4.7.2. Product Strategy
23.3.4.7.3. Channel Strategy
23.3.5. Terumo Corporation
23.3.5.1. Overview
23.3.5.2. Product Portfolio
23.3.5.3. Analyst Commentary
23.3.5.4. Key Financials
23.3.5.5. Recent Developments
23.3.5.6. Sales Footprint
23.3.5.7. Strategy Overview
23.3.5.7.1. Marketing Strategy
23.3.5.7.2. Product Strategy
23.3.5.7.3. Channel Strategy
23.3.6. Guerbet
23.3.6.1. Overview
23.3.6.2. Product Portfolio
23.3.6.3. Analyst Commentary
23.3.6.4. Key Financials
23.3.6.5. Recent Developments
23.3.6.6. Sales Footprint
23.3.6.7. Strategy Overview
23.3.6.7.1. Marketing Strategy
23.3.6.7.2. Product Strategy
23.3.6.7.3. Channel Strategy
23.3.7. Emboflu
23.3.7.1. Overview
23.3.7.2. Product Portfolio
23.3.7.3. Analyst Commentary
23.3.7.4. Key Financials
23.3.7.5. Recent Developments
23.3.7.6. Sales Footprint
23.3.7.7. Strategy Overview
23.3.7.7.1. Marketing Strategy
23.3.7.7.2. Product Strategy
23.3.7.7.3. Channel Strategy
24. Assumptions and Acronyms Used
25. Research Methodology
Table 01: Global Liquid Embolic Market Volume (Units) Analysis 2016-2020 and Forecast 2021-2031, By ProductTable 02: Global Liquid Embolic Market Volume (Units) Analysis 2016-2020 and Forecast 2021-2031, By Region
Table 03: Global Liquid Embolic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product
Table 04: Global Liquid Embolic Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 05: Global Liquid Embolic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 06: Global Liquid Embolic Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region
Table 07: Global Liquid Embolic Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region
Table 08: North America Liquid Embolic Market Volume (Units) Analysis 2016-2020 and Forecast 2021-2031, By Product
Table 09: North America Liquid Embolic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product
Table 10: North America Liquid Embolic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 11: North America Liquid Embolic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 12: North America Liquid Embolic Market Size Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 13: Latin America Liquid Embolic Market Volume (Units) Analysis 2016-2020 and Forecast 2021-2031, By Product
Table 14: Latin America Liquid Embolic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product
Table 15: Latin America Liquid Embolic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 16: Latin America Liquid Embolic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 17: Latin America Liquid Embolic Market Size Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 18: Europe Liquid Embolic Market Volume (Units) Analysis 2016-2020 and Forecast 2021-2031, By Product
Table 19: Europe Liquid Embolic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product
Table 20: Europe Liquid Embolic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 21: Europe Liquid Embolic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 22: Europe Liquid Embolic Market Size Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 23: South Asia Liquid Embolic Market Volume (Units) Analysis 2016-2020 and Forecast 2021-2031, By Product
Table 24: South Asia Liquid Embolic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product
Table 25: South Asia Liquid Embolic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 26: South Asia Liquid Embolic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 27: South Asia Liquid Embolic Market Size Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 28: East Asia Liquid Embolic Market Volume (Units) Analysis 2016-2020 and Forecast 2021-2031, By Product
Table 29: East Asia Liquid Embolic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product
Table 30: East Asia Liquid Embolic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 31: East Asia Liquid Embolic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 32: East Asia Liquid Embolic Market Size Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 33: Oceania Liquid Embolic Market Volume (Units) Analysis 2016-2020 and Forecast 2021-2031, By Product
Table 34: Oceania Liquid Embolic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product
Table 35: Oceania Liquid Embolic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 36: Oceania Liquid Embolic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 37: Oceania Liquid Embolic Market Size Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 38: MEA Liquid Embolic Market Volume (Units) Analysis 2016-2020 and Forecast 2021-2031, By Product
Table 39: MEA Liquid Embolic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product
Table 40: MEA Liquid Embolic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 41: MEA Liquid Embolic Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 42: MEA Liquid Embolic Market Size Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country